Abstract: The Invention is a method of providing medical diagnostic services. An examination provider subscribes to a subscriber network and receives examination equipment, protocols and training during the term of the examination provider's subscription as a benefit of that subscription. The examination provider conducts physical examinations of patients utilizing the examination equipment and provides examination data to an evaluating entity. The evaluating entity evaluates the data using an automated expert system. A network administrator submits claims for payment to payors and pays a testing fee to the examination provider and a reading fee to the evaluating entity.

Abstract: A Comprehensive Neuromuscular Profiler (CNMP) allows the observation of human and equine muscle functionality and characteristics. The CNMP consists of an integrated system which combines EMG technology, electromagnetic range-of-motion (ROM) technology, and functional capacity sensors. Output signals from the devices are digitized and stored in computer memory. The data may be transmitted to a server computer for further analysis. The server computer examines the data to determine patterns and consults an expert database to determine a diagnosis based on the patterns and combinations of patterns detected.

Abstract: A motorized auger comprising a frame with a pair of handles secured to the frame. Each handle having a proximal and a distal end thereto and a pair of downwardly depending support elements. A first wheel is secured to the distal ends of the pair of handles by frame elements and a rear set of wheels is secured to the proximal ends of the pair of handles by frame elements. A drive mechanism includes a chain and a sprocket operably linked to a drive engine and to a wheel, the wheel having an internal brake drum and internal brake shoes. The internal brake drum and internal brake shoes are linked to a brake cable having a cam for tension reduction secured thereto. A throttle mechanism is engaged to the drive engine and an auger is mounted to the frame. The auger is linked to a hydraulic drive motor and the auger and the hydraulic drive motor are secured to an auger mounting track element.

Abstract: The invention provides a composition for use in the recovery of precious metals, or the treatment and/or purification of water, the composition being selected from a catolytic solution having a pH greater than 7, an anolytic solution having a pH less than 7, and a near-neutral solution having a pH near 7, or a mixture of two or more of said solutions. The invention also relates to a process for the recovery of precious metals from precious metal-bearing ore using the above composition. Further, there is provided a process for making a composition, the process comprising activating water by subjecting it to a magnetic treatment; subjecting the water to electrolysis in a reactor; introducing additives to the activated water in the reactor to form a reaction mixture; subjecting the reaction mixture to photoelectrolysis and/or radioelectrolysis; and separating an anolyte and catholyte in the reactor.

Abstract: A motorized wheelbarrow comprising a frame having a pair of handles with each handle having a proximal and a distal end and a pair of downwardly depending support elements. A first wheel is secured to the distal ends of the pair of handles by a frame element and a rear set of wheels is secured to the proximal ends of the pair of handles by a frame element. A mounting element is secured to the frame for supporting a drive engine. A drive mechanism including a chain and a sprocket is operably linked to a toothed wheel and to the drive engine. The toothed wheel includes an internal brake drum and internal brake shoes. A centrifugal clutch for engagement with the drive mechanism is operably engaged to a throttle mechanism and to the drive engine, and a load bucket is mounted to the frame.

Abstract: A rigid ultrasonic radiating plate system assembly designed for fastening to bottom/planes of an ultrasonic cleaning tank. As an initial sub-assembly, the plate has selected threaded bolts/studs which are fitted/welded in a pattern perpendicular to the bottom of the plate. This plate sub-assembly component is fitted through the selected tank plane (bottom/wall), by simultaneously matching the entire bolt/stud hole pattern through to the outside of the tank and on the inside of the tank against the surface of the bottom/wall.

Abstract: In this invention, the purpose is to provide a shelf-stable spray-dried powder embodying a desired organic oil, such as a flavorant, for example. First, hydroxylated lecithin is subject to a high-energy power input, such as by vigorous stirring or microfluidization or sonication. To make a uniform mix, the resultant product is mixed with a poloxamer surfactant, water, and the desired organic oil, whether it be a flavoring, insect repellent, paint base or other organic oil. This is then subjected to energization input again, such as by microfluidization or sonication. Following this, bulking agents are added and the mixture is spray-dried. This invention shows the novel improvement of spray-dried material of the oil, lecithin, and surfactant to produce an extended shelf-life with little escape of organic oil ingredient.

Abstract: This invention discloses the phenomenon of physically sequestering organic soluble material by lamellar envelopment. It is to be distinguished from microdroplets of water insoluble drugs coated with a phospholipid prepared by sonication. Actual reduction to practice in a commercial effort has been with insect repellent. Hence, the disclosure will refer essentially to the dispersing of DEET.

Abstract: The first part explains the discovery, and means to employ the discovery that whole, intact vesicles and liposomes are not the sole means of burden (drug) delivery by targeting molecules. The second part teaches the discovery of reverse loading of vesicles and liposomes to obtain fully functional core volume load of a useful burden without the trauma degradation of the active burden material, and with greatly extended shelf life.

Abstract: Mucin coated Sepharose is used as a laboratory model to measure the affinity of a postulated lipid composition in liposome configuration for binding to mucin. The preferred lipid composition provides a first lipid moiety which projects a postive charged ion. A second lipid moiety enhances the positive charge by neutralizing all intermediate negative charges of the first lipid. The result is a liposome with strong postive charge areas which will bind to mucin.

Abstract: Peripherally administered insulin fails to provide liver hormone function. Hepatocyte directed vesicles with encapsulated insulin will restore liver function, but there is no non-targeted insulin to bypass the liver for peripheral use, as in natural, healthy body function.Whenever a prescribed dosage of insulin is divided between free and encapsulated hepatocyte targeted forms, a very small fraction of the dose in encapsulated form is sufficient to elicit full liver function, and non-targeted insulin supplies the needs of the body muscle and tissue.

Abstract: A known procedure is used to prepare liposomes of bipolar lipid membrane which are permeable and hence "leak" their contents at a rate which is variable by choice. The liposome is supplied with medication or cosmetic material for the oral cavity, or specifically for the teeth and gums. The liposome is then attached to a molecule that has affinity for the hydroxyapatite. Thus, the liposome will bind to oral cavity hydroxyapatite and bathe the surrounding support surface with its contents for extended hours of service.

Abstract: A discovery that insulin alone does not fully control liver function of glucose uptake, release, and synthesize. A second hormone, serotonin, is released in the portal vein as a function of glucose presence in the gut and portal vein. In the absence of the portal serotonin, the liver will not take up and store glucose, and will, in fact, synthesize more glucose.Adult onset diabetics generally do not have a lack of natural insulin. Whenever a serotonin deficiency is the lacking control factor, this hormone is supplied by a hepatocyte diected vesicle (HDV) containing serotonin timed to reach the liver with the supply of glucose from a meal.

Abstract: This disclosure recognizes the fact that the technology of making vesicles from lecithin and lecithin-like molecules, although well known and highly developed, is associated with problems of instability. It is known that vesicles coalesce, rupture and spill their contents long before the vesicle is used for its intended purpose.It has been discovered and disclosed herein that the deterioration of the vesicle delivery system is due in part to the rupture of the bipolar lipid vesicle membrane by the contents of the core volume or by an external agent. For example, the more detergent-like the properties of the pharmacological agent within the vesicle core volume, the more pronounced will be the attack on the vesicle wall interior. These events in turn will lead to vesicle membrane rupture.

Abstract: This disclosure teaches a method of inactivating bacterial toxins, such as produced by Vibrio cholerae and Escherichia coli (hereinafter V. cholerae and E. coli) that are responsible for diarrhea in warm-blooded animals, comprising the placing of an effective dosage of ascorbic acid salts thereof, or derivatives such as the ester ascorbyl palmitate in the intestinal tract.Definition: Ascorbic acid, salts thereof, and derivatives thereof such as ascorbyl palmetate have been identified as suitable detoxifying material according to this invention. For the sake brevity, the term "ascorbic acid" hereinafter shall include the salts and esters.Diarrhea as used herein will include other toxins effecting the lower duodenum and intestines.

Abstract: This invention is for an improved method of treating hyperkinetic behavior based on the discovery of the etiology of the disorder. The genesis of the invention is in the discovery that constant overactivity, distractibiity, impulsiveness, and aggressiveness, is frequently related to hypoglycemia. It has been discovered that hyperkinetic behavior due to moderate hypoglycemia will respond favorably, to the treatment of hypoglycemia. Hypoglycemia occurs during fasting and is due to an inappropriate presence of serotonin at the liver. Serotonin is a key hormone in conjunction with insulin to program liver glucose control. From this, the method is described of using a serotonin antagonist or an agent to block synthesis and/or storage of serotonin after glucose is no longer supplied to the portal vein. Then the liver can cease glucose uptake and begin production of glucose for the peripheral blood supply. The preferred serotonin antagonist is cyproheptadine.

Abstract: A targeted drug delivery system which has specificity for hepatobiliary receptors, which are the specialized metabolic cells of the liver. Hereinafter, this will be referred to as a Hepatocyte Directed Vesicle, or abbreviated as HDV. This preferred directed delivery system utilizes a bipolar lipid for the majority of its vesicle membrane structure.The targeting material, which is only a minor constituent of a targeted vesicle system, has a specificity for hepatobiliary receptors of the liver. The Hepatocyte Directed Vesicle is then attracted to the receptor, and the vesicle releases its pharmacological cargo.This disclosure specifies that the attachment of the targeting material, or molecule, to the vesicle is preferably done by first providing a connector molecule, having a portion inserted into the wall of the vesicle, by reason of being lipophilic, and a portion which is hydrophilic and is projected from the vesicle wall.

Abstract: This invention is for an improved method of treating the disease of hypoglycemia (low blood glucose), based on the discovery by the inventor of the etiology of the disease. The genesis of this invention is in the discovery that insulin alone does not control the uptake and regeneration of glucose by the liver. It has been discovered that hepatic storage of glucose following a meal requires the related function of insulin and serotonin. Hypoglycemia occurs during fasting and is due to an inappropriate release of serotonin to the liver. From this, the method of using a serotonin antagonist or an agent to block synthesis and/or storage of serotonin in timed relationship to ingested food to stop the action or the production of serotonin after glucose is no longer supplied to the portal vein is described. Then the liver can cease glucose uptake and begin production of glucose for the peripheral blood supply. The preferred antagonist is cyproheptadine.

Abstract: This invention relates to a method of prophylaxis with respect to Toxic Shock Syndrome in warm blooded animals, comprising the placing of a propylactically effective dosage of ascorbic acid in the vagina or in the area of the vagina.